Overbought Stocks — Valuation View · Biological Products, (No Diagnostic Substances)
8 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Valuation columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–8 of 8
| TARS | Tarsus Pharmaceuticals, Inc. | $3.6B | -78.48 | 6.02 | 10.52 | 17.83 | 0.0% | 83.12 | +0.41% | 43K |
| APGE | Apogee Therapeutics, Inc. | $10.2B | -34.57 | — | — | 96.40 | — | 135.08 | +0.04% | 89K |
| ALVO | Alvotech | — | — | — | — | — | — | 5.37 | +0.56% | 74K |
| HALO | Halozyme Therapeutics, Inc. | $12.6B | 30.39 | 7.55 | 87.56 | 77.04 | — | 110.73 | +1.01% | 90K |
| ATTO | Attovia Therapeutics, Inc. | $1.2B | — | — | — | 35.22 | — | 25.33 | +3.56% | 23K |
| NVAX | Novavax Inc | $1.7B | -6.88 | 1.52 | — | 8.91 | — | 10.34 | +0.19% | 229K |
| CRDL | Cardiol Therapeutics Inc. | — | — | — | — | — | — | 2.15 | -0.23% | 66K |
| IOVA | Iovance Biotherapeutics, Inc. | $4.0B | -13.77 | 12.27 | 5.42 | 35.99 | — | 8.80 | +2.09% | 641K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.